GlassScriptPhysician profile
Fotios D Vrionis
NPI 1083640403
$17,807.32
in general payments reported to CMS, 2019-2025
63 companies · $1,795 in 2025
The $1,795 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,117 · 2020: $3,451 · 2021: $2,547 · 2022: $3,619 · 2023: $1,230 · 2024: $1,046 · 2025: $1,795.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,052 · Education: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,051.80 |
| Education | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $5,242.46 | 2021-2025 | Unid_pass, Synchromedii, Intellis Adaptivestim |
| Abbott Laboratories | $2,762.73 | 2019-2023 | Proclaim |
| Life Spine, INC. | $1,744.06 | 2019-2020 | |
| Stryker Corporation | $975.17 | 2019 | |
| Zap Surgical Systems, INC. | $594.73 | 2019-2022 | |
| Abbvie INC. | $533.91 | 2023-2025 | Botox, Duopa |
| Depuy Synthes Sales INC. | $524.94 | 2019-2022 | |
| Surgentec | $500.00 | 2022 | |
| Biocomposites INC | $404.37 | 2020-2022 | |
| Acadia Pharmaceuticals INC | $337.78 | 2019-2025 | Nuplazid |
| Csl Behring | $337.18 | 2019-2024 | Kcentra |
| Baxter Healthcare | $300.77 | 2019-2025 | Floseal, Perclot |
| Monteris Medical Corporation | $250.49 | 2020-2023 | Neuroblate |
| Medtronic USA, INC. | $242.95 | 2019-2020 | |
| Emd Serono, INC. | $194.29 | 2020-2024 |
Show all 63 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fotios Vrionis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.